Metabolic and bariatric surgery for Type 2 diabetics with BMI <35: the time is now

摘要

Diabetes and obesity are twin epidemics that we are currently facing in the USA. More than 25 million adults in the USA are Type 2 diabetic and 79 million are pre-diabetic. This number continues to grow and has almost tripled in the past 20 years. Obesity is a major independent risk factor for developing Type 2 diabetes. More than a third of adults are obese and 90% of Type 2 diabetics are overweight or obese [1,2]. Current treatment for Type 2 diabetics with class I obesity is intensive medical management, which has shown poor to mixed results. There have been several randomized control trials and systemic reviews looking at nonsurgical treatment of class I obesity.